Akèy › Anplwayè › Colossal Biosciences, Inc.
Colossal Biosciences, Inc.: Salè H-1B ak pajon
Colossal Biosciences, Inc. depoze 11 aplikasyon kondisyon travay pou visa H-1B ak visa ki gen rapò nan ane fiskal 2023–2026; sètifye: 10. Medyèn salè yo ofri a: $127,500.
Èske Colossal Biosciences, Inc. pajone visa H-1B?
Colossal Biosciences, Inc. depoze 11 aplikasyon kondisyon travay nan ane fiskal 2023–2026, dènye a soumèt sou Apr 28, 2026. Yon LCA se premye etap yon demann H-1B, konsa anplwayè a pajone oswa prepare pou pajone travayè H-1B; li pa garanti pajon pou okenn travay espesifik. Tcheke lis travay pwòp anplwayè a.
Salè pa tit travay
| Tit travay | LCA | Salè medyan |
|---|---|---|
| Scientist, Genome Engineering | 4 | $125,000 |
| Lead Marsupial Reproductive Scientist | 1 | $130,000 |
| Associate, Genome Engineering | 1 | $80,000 |
| Marsupial Assisted Reproduction Lead | 1 | $130,000 |
| Embryologist | 1 | $145,000 |
| Stem Cell Biology Scientist | 1 | $130,000 |
| Scientist II | 1 | $136,080 |
| Senior Research Associate | 1 | $100,045 |
Aplikasyon pa ane fiskal
| Ane fiskal | LCA | Salè medyan |
|---|---|---|
| FY2023 | 1 | $130,000 |
| FY2024 | 6 | $125,000 |
| FY2025 | 1 | $125,000 |
| FY2026 | 3 | $130,000 |
Nivo salè prevanlan
Depatman Travay la etabli kat nivo salè prevanlan pou chak okipasyon ak zòn, soti nan Nivo I (antre) rive nan Nivo IV (plen kompetans). Anplwayè a chwazi nivo ki koresponn ak kondisyon travay la.
Kote travay yo ye
Okipasyon
Dènye aplikasyon yo
| Tit travay | Salè baz | Kote | Soumèt | Dat kòmansman | Estati |
|---|---|---|---|---|---|
| Senior Research Associate | $100,045 Nivo III | Dallas, TX | Apr 28, 2026 | Oct 1, 2026 | Certifye |
| Scientist II | $136,080 Nivo IV | Dallas, TX | Apr 28, 2026 | Oct 1, 2026 | Certifye |
| Scientist, Genome Engineering | $125,000 Nivo III | Dallas, TX | Mar 21, 2025 | Apr 1, 2025 | Certifye |
| Scientist, Genome Engineering | $125,000 Nivo III | Dallas, TX | Aug 13, 2024 | Oct 1, 2024 | Certifye |
| Scientist, Genome Engineering | $125,000 Nivo III | Dallas, TX | Aug 8, 2024 | Feb 3, 2025 | Retire |
| Associate, Genome Engineering | $80,000 Nivo II | Dallas, TX | Apr 29, 2024 | Oct 1, 2024 | Certifye |
| Marsupial Assisted Reproduction Lead | $130,000 E-3 · Nivo III | Dallas, TX | Apr 16, 2024 | Jul 1, 2024 | Certifye, apre retire |
| Scientist, Genome Engineering | $125,000 Nivo III | Dallas, TX | Apr 16, 2024 | Oct 1, 2024 | Certifye |
| Lead Marsupial Reproductive Scientist | $130,000 E-3 · Nivo IV | Dallas, TX | Oct 7, 2022 | Nov 15, 2022 | Certifye |
| Stem Cell Biology Scientist | $130,000 Nivo III | Cambridge, MA | May 16, 2022 | Oct 1, 2022 | Certifye, apre retire |
| Embryologist | $145,000 Nivo III | Dallas, TX | Apr 27, 2022 | Oct 1, 2022 | Certifye, apre retire |
Salè yo se fen ki pi ba nan salè yo ofri sou chak aplikasyon, konvèti nan yon montan anyèl; estatistik yo itilize sèlman aplikasyon tan plen sètifye. Yon LCA pa yon apwobasyon visa epi yon sèl LCA ka kouvri plizyè pozisyon. Sous: Depatman Travay Etazini, Done Divulgasyon LCA OFLC, ane fiskal 2023–2026 (dènye desizyon Jun 30, 2026).